SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001239241-08-000005
Filing Date
2008-06-05
Accepted
2008-06-05 18:15:47
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3852
  Complete submission text file 0001239241-08-000005.txt   5724
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA RM 5508 NEW YORK NY 21264957
Business Address
EVNIN ANTHONY B (Reporting) CIK: 0001239241 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 08884044